Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions
Identifieur interne : 005E88 ( Main/Exploration ); précédent : 005E87; suivant : 005E89Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions
Auteurs : J. G. Nutt [États-Unis] ; J. H. Carter ; W. Woodward ; J. P. Hammerstad ; S. T. GancherSource :
- Movement disorders [ 0885-3185 ] ; 1993.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 003754
- to stream PascalFrancis, to step Curation: 003070
- to stream PascalFrancis, to step Checkpoint: 003737
- to stream Main, to step Merge: 009157
- to stream Main, to step Curation: 005E88
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions</title><author><name sortKey="Nutt, J G" sort="Nutt, J G" uniqKey="Nutt J" first="J. G." last="Nutt">J. G. Nutt</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Oregon health sci. univ., school medicine, dep. neurology</s1><s2>Portland OR 97201</s2><s3>USA</s3></inist:fA14><country>États-Unis</country><wicri:noRegion>Portland OR 97201</wicri:noRegion></affiliation></author><author><name sortKey="Carter, J H" sort="Carter, J H" uniqKey="Carter J" first="J. H." last="Carter">J. H. Carter</name></author><author><name sortKey="Woodward, W" sort="Woodward, W" uniqKey="Woodward W" first="W." last="Woodward">W. Woodward</name></author><author><name sortKey="Hammerstad, J P" sort="Hammerstad, J P" uniqKey="Hammerstad J" first="J. P." last="Hammerstad">J. P. Hammerstad</name></author><author><name sortKey="Gancher, S T" sort="Gancher, S T" uniqKey="Gancher S" first="S. T." last="Gancher">S. T. Gancher</name></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">93-0457154</idno><date when="1993">1993</date><idno type="stanalyst">PASCAL 93-0457154 INIST</idno><idno type="RBID">Pascal:93-0457154</idno><idno type="wicri:Area/PascalFrancis/Corpus">003754</idno><idno type="wicri:Area/PascalFrancis/Curation">003070</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">003737</idno><idno type="wicri:doubleKey">0885-3185:1993:Nutt J:does:tolerance:develop</idno><idno type="wicri:Area/Main/Merge">009157</idno><idno type="wicri:Area/Main/Curation">005E88</idno><idno type="wicri:Area/Main/Exploration">005E88</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions</title><author><name sortKey="Nutt, J G" sort="Nutt, J G" uniqKey="Nutt J" first="J. G." last="Nutt">J. G. Nutt</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Oregon health sci. univ., school medicine, dep. neurology</s1><s2>Portland OR 97201</s2><s3>USA</s3></inist:fA14><country>États-Unis</country><wicri:noRegion>Portland OR 97201</wicri:noRegion></affiliation></author><author><name sortKey="Carter, J H" sort="Carter, J H" uniqKey="Carter J" first="J. H." last="Carter">J. H. Carter</name></author><author><name sortKey="Woodward, W" sort="Woodward, W" uniqKey="Woodward W" first="W." last="Woodward">W. Woodward</name></author><author><name sortKey="Hammerstad, J P" sort="Hammerstad, J P" uniqKey="Hammerstad J" first="J. P." last="Hammerstad">J. P. Hammerstad</name></author><author><name sortKey="Gancher, S T" sort="Gancher, S T" uniqKey="Gancher S" first="S. T." last="Gancher">S. T. Gancher</name></author></analytic><series><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno><imprint><date when="1993">1993</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson agent</term><term>Chemotherapy</term><term>Dopa</term><term>Human</term><term>Parkinson disease</term><term>Tolerance limit</term><term>Treatment</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term><term>Traitement</term><term>Homme</term><term>Chimiothérapie</term><term>Dopa</term><term>Limite tolérance</term><term>Antiparkinsonien</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><noCountry><name sortKey="Carter, J H" sort="Carter, J H" uniqKey="Carter J" first="J. H." last="Carter">J. H. Carter</name><name sortKey="Gancher, S T" sort="Gancher, S T" uniqKey="Gancher S" first="S. T." last="Gancher">S. T. Gancher</name><name sortKey="Hammerstad, J P" sort="Hammerstad, J P" uniqKey="Hammerstad J" first="J. P." last="Hammerstad">J. P. Hammerstad</name><name sortKey="Woodward, W" sort="Woodward, W" uniqKey="Woodward W" first="W." last="Woodward">W. Woodward</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Nutt, J G" sort="Nutt, J G" uniqKey="Nutt J" first="J. G." last="Nutt">J. G. Nutt</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005E88 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005E88 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:93-0457154
|texte= Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions
}}
| This area was generated with Dilib version V0.6.23. |  |